Clinical Trials Browser

OTHER × S 1 (combination) × Head & Neck × Clear all

NCT07070479 2025-09-18

Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial

Phase 2 Recruiting

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

NCT06657690 2025-01-10

Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC

Phase 2 Recruiting

Nasopharyngeal Carcinoma, Recurrence

NCT03267121 2023-10-17

A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03668366 2021-02-11

S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT03654612 2018-10-18

Y-HR2017-025

Phase 1/2 Unknown

Head and Neck Neoplasms

NCT02878889 2017-01-11

A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma.

Phase 2 Unknown

Nasopharyngeal Carcinoma

NCT02943252 2016-10-24

The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer

Phase 2 Unknown

Head and Neck Neoplasms

NCT01403259 2014-08-20

SOX as Salvage Treatment in Nasopharyngeal Carcinoma

Phase 2 Terminated

Nasopharyngeal Carcinoma

NCT01645748 2012-07-20

TPSHNSCC

Phase 2 Completed

Head and Neck Neoplasms